SPAC19D5.02c Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC19D5.02c; Uncharacterized protein C19D5.02c
Target Names
SPAC19D5.02c
Uniprot No.

Target Background

Database Links
Subcellular Location
Endoplasmic reticulum membrane; Single-pass membrane protein.

Q&A

What is SPAC19D5.02c and why is it important in S. pombe research?

SPAC19D5.02c encodes a predicted peroxisomal membrane protein Pex22 in Schizosaccharomyces pombe (fission yeast). Pex22 is a crucial component of peroxisomal biogenesis and function, serving as a membrane anchor for the Pex4p ubiquitin conjugating enzyme. Understanding this protein's localization and interactions is essential for characterizing peroxisome dynamics in eukaryotic model organisms. The protein plays key roles in peroxisomal matrix protein import and organelle maintenance, making it a valuable target for studying fundamental cellular processes involving organelle biogenesis and membrane protein trafficking.

What validation methods should be used to confirm SPAC19D5.02c antibody specificity?

Validation of SPAC19D5.02c antibodies requires multiple complementary approaches:

  • Western blot analysis comparing wild-type S. pombe strains with SPAC19D5.02c deletion mutants to confirm absence of signal in knockout strains

  • Immunofluorescence microscopy showing co-localization with known peroxisomal markers

  • Detection of recombinant SPAC19D5.02c protein expressed in bacterial or insect cell systems

  • Peptide competition assays to demonstrate epitope-specific binding

  • Cross-validation using orthogonal detection methods (e.g., mass spectrometry of immunoprecipitated samples)

For rigorous antibody validation, researchers should observe a single band at the predicted molecular weight (~35-40 kDa for Pex22) that disappears in knockout strains and in peptide competition assays. The signal should co-localize with peroxisomal markers in immunofluorescence studies.

What are the recommended primary applications for SPAC19D5.02c antibodies?

SPAC19D5.02c antibodies are most commonly employed in the following research applications:

ApplicationRecommended DilutionKey Considerations
Western Blot1:500 - 1:2000Use mild detergents like 0.1% Triton X-100 for membrane protein extraction
Immunofluorescence1:100 - 1:500Permeabilization optimization critical for membrane protein detection
Immunoprecipitation1:50 - 1:200Cross-linking may improve recovery of membrane-bound complexes
Flow Cytometry1:100 - 1:500Limited application due to yeast cell wall; spheroplasting required

Each application requires optimization based on the specific antibody characteristics and experimental conditions. For membrane proteins like Pex22, extraction conditions significantly impact antibody performance.

How can epitope accessibility issues be overcome when detecting the SPAC19D5.02c-encoded Pex22 protein?

As a peroxisomal membrane protein, Pex22 presents unique challenges for antibody detection due to epitope masking within the lipid bilayer. Several methodological approaches can enhance detection:

  • Membrane protein extraction optimization: Use specialized detergent combinations (CHAPS/digitonin/DDM) at concentrations determined through systematic titration experiments.

  • Selective permeabilization protocols: For immunofluorescence, implement a dual-detergent approach using 0.1% Triton X-100 followed by 0.05% saponin to preserve organelle morphology while increasing membrane permeability.

  • Epitope retrieval techniques: Apply heat-mediated (95°C, 10 minutes in citrate buffer, pH 6.0) or enzymatic antigen retrieval methods (limited proteinase K digestion) for fixed samples.

  • Multiple antibody strategy: Employ antibodies targeting different epitopes of Pex22, particularly against predicted extramembrane loops or termini, to increase detection probability.

For research requiring quantitative analysis, standardize extraction efficiency using an internal control protein with similar membrane topology but distinct molecular weight.

What are the optimal co-immunoprecipitation conditions for identifying SPAC19D5.02c/Pex22 interaction partners?

Identifying physiologically relevant interaction partners of membrane proteins like Pex22 requires careful optimization of co-immunoprecipitation protocols:

  • Crosslinking approach: Use membrane-permeable crosslinkers like DSP (dithiobis[succinimidyl propionate]) at 0.5-2 mM for 30 minutes at room temperature to stabilize transient membrane protein interactions.

  • Detergent selection: Employ digitonin (0.5-1%) or CHAPS (0.3-1%) instead of stronger ionic detergents to preserve weak protein-protein interactions within membrane complexes.

  • Buffer composition: Include 10% glycerol, 1 mM EDTA, and 150-300 mM NaCl to stabilize protein complexes while minimizing non-specific interactions.

  • Bead selection: Use magnetic beads conjugated with Protein G for monoclonal antibodies or Protein A for polyclonal antibodies, with pre-clearing steps to reduce background.

  • Elution strategy: Consider native elution with competing peptides rather than denaturing elution to maintain complex integrity for downstream applications.

When analyzing results, it's critical to include appropriate controls including IgG-only precipitations and precipitations from Pex22-deletion strains to distinguish true interactors from background proteins.

How can researchers distinguish between specific and non-specific signals when using SPAC19D5.02c antibodies in S. pombe?

Distinguishing specific from non-specific signals is particularly challenging with yeast membrane proteins like Pex22. Implement the following rigorous controls and analytical approaches:

  • Genetic validation using multiple strain backgrounds:

    • Wild-type S. pombe

    • SPAC19D5.02c deletion mutant

    • SPAC19D5.02c-tagged strain (e.g., GFP-tagged or epitope-tagged)

    • Overexpression strain

  • Analytical controls:

    • Pre-immune serum or isotype-matched irrelevant antibody

    • Peptide competition assay with immunizing peptide

    • Secondary antibody-only control

    • Signal quantification across multiple independent experiments

  • Signal interpretation framework:

    • Specific Pex22 signal should correspond to expected molecular weight (~35-40 kDa)

    • Signal intensity should correlate with known expression levels across conditions

    • Signal should be absent or significantly reduced in knockout strains

    • Signal should compete away with immunizing peptide

For borderline cases, complementary approaches such as mass spectrometry validation of immunoprecipitated material can provide definitive confirmation of antibody specificity.

What considerations are important when designing experiments to study SPAC19D5.02c/Pex22 dynamics during peroxisome biogenesis?

Studying the dynamic behavior of Pex22 during peroxisome biogenesis requires careful experimental design:

  • Temporal resolution: Implement time-course experiments with synchronized cultures or inducible systems to capture rapid changes in Pex22 localization and abundance.

  • Spatial resolution: Use super-resolution microscopy techniques (STED, PALM, or SIM) to distinguish between different peroxisomal subcompartments, as conventional microscopy cannot resolve these structures adequately.

  • Physiological induction: Design experiments incorporating physiologically relevant peroxisome-inducing conditions:

    • Oleic acid (0.1-0.5%) as carbon source

    • Methanol (for heterologous systems)

    • Hydrogen peroxide stress (0.1-1 mM)

  • Multi-parameter analysis: Simultaneously track multiple parameters including:

    • Pex22 protein levels by quantitative immunoblotting

    • Pex22 localization by immunofluorescence

    • Peroxisome number and morphology

    • Interaction partners through proximity labeling approaches

  • Dynamic protein complex assembly: Consider implementing split-GFP or FRET-based approaches to monitor the assembly of Pex4-Pex22 complexes in real-time under different physiological conditions.

When interpreting results, account for the heterogeneity of peroxisome populations within single cells and across a population, as this can significantly impact experimental outcomes.

What are the common technical issues when detecting SPAC19D5.02c protein and how can they be resolved?

Researchers frequently encounter several challenges when working with antibodies against the peroxisomal membrane protein Pex22:

  • Low signal intensity:

    • Cause: Low abundance of endogenous Pex22 or inefficient extraction

    • Solution: Implement membrane protein enrichment protocols using differential centrifugation; consider using chemiluminescent substrates with longer exposure times; optimize cell lysis buffers with increased detergent concentration

  • Multiple non-specific bands:

    • Cause: Cross-reactivity with related proteins or inadequate blocking

    • Solution: Increase blocking stringency (5% BSA instead of 3%); perform antibody pre-adsorption against total protein extract from Pex22 deletion strains; use gradient gels to improve separation

  • Inconsistent results across experiments:

    • Cause: Variations in extraction efficiency or protein degradation

    • Solution: Standardize cell culture conditions; include protease inhibitor cocktails optimized for yeast; maintain consistent sample processing times

  • Background in immunofluorescence:

    • Cause: Autofluorescence from yeast cell wall or non-specific binding

    • Solution: Include quenching steps with sodium borohydride; implement more stringent washing with PBS containing 0.1% Tween-20; use confocal microscopy to reduce out-of-focus fluorescence

Systematically testing these parameters is essential for establishing a reliable detection protocol for this challenging membrane protein.

How can researchers validate antibody performance across different experimental conditions for SPAC19D5.02c?

Antibody performance can vary significantly across experimental conditions when studying membrane proteins like Pex22. A comprehensive validation approach includes:

  • Cross-condition validation matrix:

Condition VariableValidation MethodExpected Outcome
Growth phaseWestern blot of log vs. stationaryConsistent relative signal patterns
Carbon sourceWestern blot of glucose vs. oleic acidIncreased signal in oleic acid
Fixation methodIF with PFA vs. methanolOptimal signal with method-specific dilutions
Extraction bufferWestern blot with different detergentsSystematic differences in signal strength
TemperatureIP at 4°C vs. room temperatureTypically stronger signal at 4°C
  • Quantitative validation approaches:

    • Standard curve generation using recombinant protein

    • Signal-to-noise ratio determination across conditions

    • Coefficient of variation calculation for technical and biological replicates

  • Orthogonal validation strategies:

    • Comparison with mass spectrometry-based quantitation

    • Correlation with transcript levels from RNA-Seq data

    • Comparison with fluorescent protein fusion signal intensity

This systematic approach enables researchers to identify optimal conditions for each experimental application while ensuring result reproducibility.

What strategies can overcome detection challenges for SPAC19D5.02c in different subcellular fractionation experiments?

Subcellular fractionation experiments with Pex22 present unique challenges due to its peroxisomal membrane localization:

  • Density gradient optimization:

    • Challenge: Peroxisomes can migrate differently depending on their maturation stage

    • Solution: Implement shallow Nycodenz gradients (15-35%) to better resolve peroxisomal subpopulations

  • Enrichment verification:

    • Challenge: Confirming successful isolation of peroxisomal fractions

    • Solution: Use established peroxisomal markers as controls (catalase, Pex3, Pex11) alongside Pex22 detection

  • Membrane vs. matrix separation:

    • Challenge: Distinguishing membrane-associated from matrix proteins

    • Solution: Implement carbonate extraction (pH 11.5) to differentiate between membrane-integrated proteins and peripherally associated proteins

  • Organelle integrity:

    • Challenge: Preserving fragile peroxisomes during isolation

    • Solution: Use gentle homogenization techniques; include sucrose or sorbitol (0.25-0.5 M) in isolation buffers; maintain samples at 4°C throughout processing

  • Detection method adaptation:

    • Challenge: Low abundance in certain fractions

    • Solution: Concentrate fractions using TCA precipitation before immunoblotting; use enhanced chemiluminescence detection systems with higher sensitivity

For quantitative analysis, normalize Pex22 signal to total protein content in each fraction and to established peroxisomal markers to control for isolation efficiency variations.

How can SPAC19D5.02c antibodies be utilized in studying peroxisome-related disease models?

While S. pombe is not a primary model for human disease, insights from Pex22 research can be translated to understanding peroxisomal biogenesis disorders:

  • Comparative analysis approach:

    • Generate fusion yeast strains expressing human PEX22 variants

    • Use SPAC19D5.02c antibodies alongside human PEX22 antibodies to study conservation of function

    • Analyze complementation capacity of human PEX22 in SPAC19D5.02c deletion strains

  • Disease-associated variants:

    • Express human PEX22 mutations associated with Zellweger spectrum disorders in S. pombe

    • Use antibodies to assess protein stability, localization, and interaction capacity

    • Correlate biochemical findings with functional peroxisome import assays

  • Stress response models:

    • Study Pex22 dynamics under oxidative stress conditions that mimic disease states

    • Monitor changes in Pex22 post-translational modifications using modification-specific antibodies

    • Analyze correlation between Pex22 status and peroxisome function in aging yeast populations

  • Drug screening applications:

    • Use SPAC19D5.02c antibodies to monitor effects of potential therapeutic compounds on peroxisome biogenesis

    • Implement high-content screening with automated immunofluorescence to assess peroxisome morphology and Pex22 localization

This translational approach can provide valuable insights into fundamental mechanisms of peroxisomal disorders while leveraging the experimental advantages of the S. pombe model system.

What is the current understanding of post-translational modifications of SPAC19D5.02c and how can they be studied with antibodies?

Post-translational modifications (PTMs) of Pex22 remain understudied but potentially critical for function. Current approaches include:

  • Phosphorylation analysis:

    • Predicted phosphorylation sites occur primarily in cytosol-exposed regions

    • Phospho-specific antibodies can be developed against these sites

    • Validation requires phosphatase treatment controls and phosphomimetic mutants

  • Ubiquitination detection:

    • Given Pex22's role as anchor for the E2 enzyme Pex4, it may itself be ubiquitinated

    • Co-immunoprecipitation with ubiquitin antibodies followed by Pex22 detection

    • Analysis under proteasome inhibition (MG132 treatment) to stabilize ubiquitinated forms

  • PTM profiling strategy:

    • Immunoprecipitate Pex22 from cells grown under different conditions

    • Analyze by mass spectrometry to identify condition-specific modifications

    • Develop modification-specific antibodies against validated sites

  • Functional correlation:

    • Correlate PTM status with peroxisome function and biogenesis rate

    • Analyze PTM dynamics during peroxisome proliferation and pexophagy

    • Study interplay between different modifications using site-specific mutants

The dynamic regulation of Pex22 through PTMs likely plays a key role in coordinating peroxisome biogenesis with cellular metabolic needs and stress responses.

How can quantitative analysis of SPAC19D5.02c be performed to understand stoichiometry in peroxisomal protein complexes?

Understanding the stoichiometry of Pex22 in protein complexes requires sophisticated quantitative approaches:

  • Absolute quantification methodology:

    • Develop a standard curve using recombinant Pex22 protein

    • Implement stable isotope dilution techniques with labeled peptides

    • Calculate molecules per cell using known cell counts and extraction efficiency

  • Complex stoichiometry determination:

    • Use quantitative immunoblotting to determine ratios of Pex22 to binding partners

    • Implement blue native PAGE to isolate intact complexes followed by antibody detection

    • Correlate with single-molecule fluorescence techniques using tagged proteins

  • Spatial distribution quantification:

    • Implement quantitative immunofluorescence with calibrated image analysis

    • Use proximity ligation assays to quantify interactions in situ

    • Correlate with electron microscopy immunogold labeling for nanoscale resolution

  • Dynamic equilibrium analysis:

    • Study assembly/disassembly kinetics using pulse-chase experiments

    • Quantify free vs. complex-bound Pex22 under different conditions

    • Implement mathematical modeling to describe complex formation dynamics

These approaches provide complementary information about the absolute and relative abundance of Pex22 in different cellular compartments and protein complexes, offering insights into the mechanistic details of peroxisome biogenesis.

How can CRISPR-based approaches enhance SPAC19D5.02c antibody specificity validation?

CRISPR-Cas9 genome editing in S. pombe has created new opportunities for antibody validation:

  • Epitope tag knock-in strategies:

    • Generate endogenous C-terminal or N-terminal tags (e.g., FLAG, HA) at the SPAC19D5.02c locus

    • Compare signal patterns between anti-Pex22 and anti-tag antibodies

    • Validate epitope accessibility in different experimental conditions

  • Deletion series analysis:

    • Create domain-specific deletions within the endogenous SPAC19D5.02c gene

    • Map epitope recognition by analyzing which deletions eliminate antibody binding

    • Generate domain-specific antibodies for studying protein topology

  • Multiplexed validation:

    • Simultaneously edit multiple peroxisomal genes to create complex mutant backgrounds

    • Analyze antibody specificity across these genetic backgrounds

    • Identify potential cross-reactivity with related peroxins

  • Validation in diverse genetic backgrounds:

    • Test antibody performance in different S. pombe strains with natural genetic variation

    • Analyze signal consistency across strains with different peroxisome morphology

    • Validate in related yeast species to assess cross-species reactivity

These approaches provide rigorous genetic controls that complement traditional biochemical validation methods, enhancing confidence in antibody specificity for challenging targets like membrane-bound peroxins.

What considerations are important when designing experiments to study conditional depletion of SPAC19D5.02c?

Conditional depletion systems offer powerful approaches to study Pex22 function with temporal control:

  • Degron-based approaches:

    • Endogenous tagging with auxin-inducible degron (AID) or temperature-sensitive degron

    • Monitoring protein depletion kinetics via quantitative immunoblotting

    • Correlating depletion with physiological effects on peroxisome biogenesis

  • Transcriptional regulation:

    • Integration of tetracycline-regulatable promoters to control SPAC19D5.02c expression

    • Antibody-based monitoring of protein decay following transcriptional shutdown

    • Analysis of threshold effects in peroxisome function

  • Critical experimental parameters:

    • Timepoint selection: Include early timepoints (15, 30, 60 minutes) to capture immediate effects

    • Cell synchronization: Consider cell cycle effects on peroxisome biogenesis

    • Recovery experiments: Monitor restoration of Pex22 levels after removal of depletion stimulus

  • Integration with functional assays:

    • Peroxisomal matrix protein import assays during depletion

    • Peroxisome morphology analysis by electron microscopy

    • Metabolomic analysis of peroxisome-dependent pathways

These conditional approaches provide insights into both immediate functions and adaptive responses to Pex22 depletion, revealing aspects of protein function that cannot be observed in conventional knockout studies.

How can advanced imaging techniques enhance the utility of SPAC19D5.02c antibodies in peroxisome research?

Cutting-edge microscopy approaches significantly expand the research applications of Pex22 antibodies:

  • Super-resolution microscopy applications:

    • STED or PALM microscopy to resolve sub-peroxisomal localization of Pex22

    • Analysis of Pex22 distribution within peroxisomal membranes at 20-50 nm resolution

    • Correlation with other peroxins to generate detailed protein maps of import machinery

  • Live-cell imaging strategies:

    • Correlative light and electron microscopy (CLEM) combining antibody detection with ultrastructural analysis

    • Single particle tracking of quantum dot-conjugated antibody fragments in semi-permeabilized cells

    • Pulse-chase imaging to track newly synthesized Pex22 using temporal labeling strategies

  • Multiplexed detection approaches:

    • Array tomography with sequential antibody labeling and stripping

    • Mass cytometry (CyTOF) adaptation for yeast using metal-conjugated antibodies

    • Spectral unmixing to simultaneously detect multiple peroxisomal proteins

  • Quantitative imaging metrics:

    • Measurement of Pex22 density per peroxisome surface area

    • Cluster analysis to identify specialized membrane domains

    • Correlation of Pex22 distribution with peroxisome functional states

These advanced imaging approaches bridge the gap between biochemical analysis and cellular function, providing spatially resolved information about Pex22 dynamics in the context of living cells.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.